How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?

被引:157
作者
Olsson, A.
Manzl, C.
Strasser, A.
Villunger, A. [1 ]
机构
[1] Innsbruck Med Univ, Div Dev Immunol, Bioctr, A-6020 Innsbruck, Austria
[2] Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Melbourne, Vic, Australia
基金
奥地利科学基金会;
关键词
p53; apoptosis; cell cycle; tumourigenesis;
D O I
10.1038/sj.cdd.4402196
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of elegant studies exploring the consequences of expression of various mutant forms of p53 in mice have been published over the last years. The results and conclusions drawn from these studies often contradict results previously obtained in biochemical assays and cell biology studies, questioning their relevance for p53 function in vivo. Owing to the multitude of post-translational modifications imposed on p53, however, the in vivo validation of their relevance for proper protein function and tumour suppression is constantly lagging behind new biochemical discoveries. Nevertheless, mouse genetics presents again its enormous power. Despite being relatively slow and tedious, it has become indispensable for researchers to sort out the wheat from the chaff in an endless sea of publications on p53.
引用
收藏
页码:1561 / 1575
页数:15
相关论文
共 170 条
[1]   FBXO11 promotes the neddylation of p53 and inhibits its transcriptional activity [J].
Abida, Wassim M. ;
Nikolaev, Anatoly ;
Zhao, Wenhui ;
Zhang, Wenzhu ;
Gu, Wei .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (03) :1797-1804
[2]   Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage [J].
Ando, T ;
Kawabe, T ;
Ohara, H ;
Ducommun, B ;
Itoh, M ;
Okamoto, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (46) :42971-42977
[3]   Post-translational modifications and activation of p53 by genotoxic stresses [J].
Appella, E ;
Anderson, CW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10) :2764-2772
[4]   HIGH-FREQUENCY DEVELOPMENTAL ABNORMALITIES IN P53-DEFICIENT MICE [J].
ARMSTRONG, JF ;
KAUFMAN, MH ;
HARRISON, DJ ;
CLARKE, AR .
CURRENT BIOLOGY, 1995, 5 (08) :931-936
[5]   Probing p53 biological functions through the use of genetically engineered mouse models [J].
Attardi, LD ;
Donehower, LA .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005, 576 (1-2) :4-21
[6]   Enhanced phosphorylation of p53 by ATN in response to DNA damage [J].
Banin, S ;
Moyal, L ;
Shieh, SY ;
Taya, Y ;
Anderson, CW ;
Chessa, L ;
Smorodinsky, NI ;
Prives, C ;
Reiss, Y ;
Shiloh, Y ;
Ziv, Y .
SCIENCE, 1998, 281 (5383) :1674-1677
[7]   The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells [J].
Baptiste, N ;
Friedlander, P ;
Chen, XB ;
Prives, C .
ONCOGENE, 2002, 21 (01) :9-21
[8]   Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases [J].
Barlev, NA ;
Liu, L ;
Chehab, NH ;
Mansfield, K ;
Harris, KG ;
Halazonetis, TD ;
Berger, SL .
MOLECULAR CELL, 2001, 8 (06) :1243-1254
[9]   Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription [J].
Blaydes, JP ;
Luciani, MG ;
Pospisilova, S ;
Ball, HML ;
Vojtesek, B ;
Hupp, TR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :4699-4708
[10]   Post-translational modification of p53 in tumorigenesis [J].
Bode, AM ;
Dong, ZG .
NATURE REVIEWS CANCER, 2004, 4 (10) :793-805